American Society of Transplant Surgeons Transplant Center outcomes requirements - A threat to innovation

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1279-1286

  Abecassis, M M ^a   Burke, R ^b   Klintmalm, G B ^c   Matas, A J ^d   Merion, R M ^e   Millman, D ^b   Olthoff, K ^f   Roberts, J P ^g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b POWERS PYLES SUTTER AND VERVILLE PC   (United States)

^c BAYLOR UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Compliance; Medicare; Regulation; Regulatory

Indexed keywords

ACCREDITATION; AMERICAN SOCIETY OF TRANSPLANT SURGEONS; ARTICLE; AVERSION; CORRELATION ANALYSIS; HEALTH CARE POLICY; HEALTH PROGRAM; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEDICAID; MEDICAL SOCIETY; MEDICARE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; TRANSPLANTATION;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DIFFUSION OF INNOVATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MEDICARE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT (HEALTH CARE); RISK ADJUSTMENT; SOCIAL RESPONSIBILITY; SOCIETIES, MEDICAL; TREATMENT OUTCOME; UNITED STATES;

EID: 66249083455     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02606.x     Document Type: Article

References (14)

1. Medicare program; hospital conditions of participation: Requirements for approval and re-approval of transplant centers to perform organ transplantation. Final Rule (42 CFR 405, 482, 488, and 498). Fed Regist 2007 72 : 15198 15280.
2. Abecassis MM, Burke R, Cosimi AB et al. on behalf of the American Society of Transplant Surgeons. Transplant center regulations-a mixed blessing? An ASTS Council viewpoint. Am J Transplant 2008 8 : 2496 2502.
3. Hamilton TE. Improving organ transplantation in the United States-A regulatory perspective. Am J Transplant 2008 8 : 2503 2505.
4. Sezer S, Ozdemir FN, Akcay A, Arat Z, Boyacioglu S, Haberal M. Renal transplantation offers a better survival in HCV-infected ESRD patients. Clin Transplant 2004 18 : 619 623. (Pubitemid 39264364)
5. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation 2008 85 : 1046 1050.
6. Shimoda M, Ghobrial RM, Carmody IC et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl 2004 10 : 1478 1486. (Pubitemid 40028380)
7. Axelrod D, Koffron A, Kulik L et al. Living donor liver transplant for malignancy. Transplantation 2005 79 : 363 366. (Pubitemid 40299547)
8. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: Results in 207 patients. Transplantation 2000 69 : 1633.
9. Luan FL, Schaubel DE, Zhang H et al. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation 2008 85 : 1601 1606.
10. Ghobrial RM, Steadman R, Gornbein J et al. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001 234 : 384 93 discussion 393-394.
11. Ghabril M, Dickson R, Wiesner R. Improving outcomes of liver retransplantation: an analysis of trends and the impact of Hepatitis C infection. Am J Transplant 2008 8 404 411.
12. Plotkin JS, Scott VL, Pinna A et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996 2 : 426.
13. Johnston SD, Morris JK, Cramb R et al. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002 73 : 901 906. (Pubitemid 34252352)
14. Jeloka TK, Ross H, Smith R et al. Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant 2007 21 : 609 614. (Pubitemid 47399424)